Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD
Status:
Completed
Trial end date:
2015-09-05
Target enrollment:
Participant gender:
Summary
The overall objective of this study was to assess the efficacy and safety of GP MDI relative
to placebo in Japanese subjects with moderate to severe COPD. Each subject received the 4
separate study treatments, scheduled as four, 7-day, treatment periods for a total treatment
duration of 28 days.